Healium is specialised in early detection of high burden diseases like Chronic Kidney Diseases (CKD) during pre-clinical stages.
They do this through explainable AI and Machine Vision driven “digital biomarkers”. Currently, CKD only gets detected when it’s
too late to be treated and patients are left to life-long dialysis or transplants. This is a large problem – globally 850 million people
are suffering from CKD and 90 percent of them are unaware of the condition.
Healium has developed an easily integratable medical SaaS product that detects CKD 10 years earlier than any existing
system. They do this by applying 3 cutting edge technologies – AI, Computer Vision and Computational Fluid Dynamics on basic
Electronic Health Records, Lab reports, and Scans. Healium has 5 paying customers (medium size hospitals with 100 beds) in India and have screened 1428 positive from launch in Feb. They have 3 patents filed and their technology is validated in collaboration with MGH – Harvard Medical School.